Silvant Capital Management LLC bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 25,811 shares of the company’s stock, valued at approximately $3,317,000.
A number of other institutional investors have also recently added to or reduced their stakes in MKGAF. LaSalle St. Investment Advisors LLC acquired a new stake in Merck KGaA in the second quarter worth approximately $2,432,000. Ceredex Value Advisors LLC acquired a new position in shares of Merck KGaA during the 2nd quarter valued at $30,371,000. Mystic Asset Management Inc. acquired a new position in shares of Merck KGaA during the 2nd quarter valued at $2,943,000. Advisors Preferred LLC bought a new stake in shares of Merck KGaA in the 2nd quarter worth $401,000. Finally, Oxford Financial Group LTD. LLC acquired a new stake in shares of Merck KGaA in the second quarter valued at $536,000. 0.10% of the stock is currently owned by institutional investors and hedge funds.
Merck KGaA Trading Down 0.9%
Shares of Merck KGaA stock opened at $162.12 on Friday. The business has a fifty day simple moving average of $162.47 and a 200-day simple moving average of $148.35. Merck KGaA has a fifty-two week low of $116.68 and a fifty-two week high of $175.56. The firm has a market cap of $20.95 billion, a price-to-earnings ratio of 24.75 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
